Type 1 Diabetes and Depression: Role of Brain Glutamate (NCT05355285) | Clinical Trial Compass
CompletedNot Applicable
Type 1 Diabetes and Depression: Role of Brain Glutamate
68 participantsStarted 2011-01
Plain-language summary
The goal of this study is to examine the effect of chronic and acute hyperglycemia in type 1 diabetes mellitus (T1DM) on brain glutamate levels using magnetic resonance spectroscopy (MRS), and associations of brain glutamate with symptoms of depression.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
T1DM Subjects:
Inclusion Criteria:
* 10-25 years duration of T1DM.
* Relatively low levels of complications from diabetes.
Exclusion Criteria:
* Type 2 diabetes and/or gestational diabetes.
* Other major clinical conditions such as cancer, symptomatic coronary artery disease, (e.g., prior myocardial infarction), stroke, proliferative diabetic retinopathy requiring a laser treatment, clinically significant diabetic nephropathy as evidenced by urinary albumin levels \> 300 mg/day and/or serum creatinine \> 1.5 mg/dl for men and \> 1.4 mg/dl for women, painful or symptomatic neuropathy, and/or diagnosed gastroparesis.
* Current or past history of attention deficit hyperactivity disorder, bipolar disorder, obsessive compulsive disorder, panic disorder, substance dependence or schizophrenia.
* Ethanol dependence and/or nicotine dependence according to Diagnostic and Statistical Manual-IV criteria and heavy smokers according to the Epidemiology of Diabetes Interventions and Complications scale 57.
Control Subjects:
Inclusion Criteria:
* No history of T1DM or Major Depressive Disorder.
* Normal fasting blood glucose, HbA1c and hematocrit levels.
Exclusion Criteria:
* Known chronic medical illness such as rheumatoid arthritis or major cardiac, kidney or liver disease or anemia.
* Current or past history of attention deficit hyperactivity disorder, bipolar disorder, obsessive compulsive disorder, panic disorder, substance dependence or schizophrenia.
* Past history of a major…
What they're measuring
1
Anterior cingulate cortex glutamate concentration during Baseline Euglycemia
Timeframe: Baseline Euglycemia
2
Change in anterior cingulate cortex glutamate concentration from Baseline Euglycemia to Hyperglycemia
Timeframe: During the MRI scanning visit with hyperglycemic clamp, up to 180 minutes